Anti-fibrillarin antibodies in systemic sclerosis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Rheumatology

• Publication date

  2001-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/RHEUMATOLOGY/40.10.1157PMID 11600746
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).

  2000cited by this paper
• Serologic abnormalities in systemic sclerosis.

  1999cited by this paper
• A disease severity scale for systemic sclerosis: development and testing.

  1999cited by this paper
• Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit.

  1999cited by this paper
• Systemic sclerosis: an autoantibody mosaic

  1999cited by this paper
• HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies.

  1998cited by this paper
• Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.

  1998cited by this paper
• Oxford Textbook of Rheumatology

  1997cited by this paper
• Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis.

  1997cited by this paper
• Anti‐RNA polymerase antibodies in systemic sclerosis (SSc): association with anti‐topoisomerase I antibodies and identification of autoreactive subunits of RNA polymerase II

  1996cited by this paper
• Manual of Biological Markers of Disease

  1996cited by this paper
• Counterimmunoelectrophoresis and immunodiffusion for the detection of antibodies to soluble cellular antigens

  1996cited by this paper
• Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.

  1996cited by this paper
• Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis.

  1996cited by this paper
• Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies.

  1994cited by this paper
• Autoantibodies in Scleroderma

  1993cited by this paper
• Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis.

  1993cited by this paper
• Racial differences in the frequencies of scleroderma-related autoantibodies.

  1992cited by this paper
• Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis.

  1992cited by this paper
• Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.

  1992cited by this paper
• Autoantibodies in scleroderma.

  1989cited by this paper
• Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma.

  1989cited by this paper
• Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma).

  1988cited by this paper
• Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

  1988cited by this paper
• Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

  1988cited by this paper
• Cellular protein and RNA antigens in autoimmune disease.

  1984cited by this paper
• Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.

  1982cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• [DETECTION OF ANTI-NUCLEAR ANTIBODIES BY IMMUNOFLUORESCENCE. (STUDY OF 1430 SERUMS)].

  1964cited by this paper

• Bibliometric insights into systemic sclerosis with renal involvement: trends, contributions, and future directions

  2025cites this paper
• Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset

  2025cites this paper
• Significance of Systemic Scleroderma-Specific Autoantibodies in Idiopathic Interstitial Pneumonia

  2024influential citation
• Autoanticorpos específicos e associados na esclerose sistêmica: investigação e diagnóstico

  2024cites this paper
• Expanding the landscape of systemic sclerosis-related autoantibodies through RNA immunoprecipitation coupled with massive parallel sequencing.

  2024cites this paper
• Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies

  2023cites this paper
• Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis

  2023cites this paper
• Autoantibodies and Clinical Correlations in Polish Systemic Sclerosis Patients: A Cross-Sectional Study

  2023cites this paper
• Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis

  2023cites this paper
• Clinical and serological correlation of systemic sclerosis in Moroccan patients

  2023influential citation
• Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes

  2022cites this paper
• Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others

  2022cites this paper
• Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis.

  2022cites this paper
• Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis

  2022influential citation
• A cell-based assay for detection of anti-fibrillarin autoantibodies with performance equivalent to immunoprecipitation

  2022cites this paper
• A Cell-Based Assay For Detection Of Anti-Fibrillarin Autoantibodies In Systemic Sclerosis

  2022cites this paper
• Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies

  2021cites this paper
• Fibrillarin antibodies in systemic sclerosis

  2021cites this paper
• Overview of Scleroderma Renal Crisis - A Review

  2021cites this paper
• Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis

  2021influential citation
• Combining multi-antigenic immunodot with indirect immunofluorescence on HEp-2 cells improves the diagnosis of systemic sclerosis.

  2021cites this paper
• Systemic sclerosis (scleroderma)

  2020cites this paper
• Nierenbeteiligung bei Kollagenosen – Teil 2: Antiphospholipid-Syndrom, primäres Sjögren-Syndrom, systemische Sklerose

  2020cites this paper
• Using Autoantibodies and Cutaneous Subset to Develop Outcome‐Based Disease Classification in Systemic Sclerosis

  2020cites this paper
• RNA Modifications Modulate Activation of Innate Toll-Like Receptors

  2019cites this paper
• Degree of Vasculopathy in Systemic Sclerosis Patients with Anti-U3RNP Antibody Indicates Need for Extensive Cardiopulmonary Screening

  2019cites this paper
• Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective

  2019cites this paper
• Clinical significance of rare serum autoantibodies in rheumatic diseases: a systematic literature review

  2018cites this paper
• Anti-nuclear autoantibodies in systemic sclerosis : News and perspectives

  2018cites this paper
• Analyse von Anti-Topoisomerase I-Antikörpern und Evaluierung ihrer immundominanten Epitope bei Patienten mit diffus kutaner systemischer Sklerose vor und nach autologer hämatopoetischer Stammzelltransplantation

  2018influential citation
• Prevalence of autoantibody patterns in a group of patients with early scleroderma

  2018cites this paper
• Bench to bedside review of myositis autoantibodies

  2018cites this paper
• Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

  2018cites this paper
• Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related Disorders

  2018cites this paper
• Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma - A review.

  2018cites this paper
• T Helper Cells in the Immunopathogenesis of Systemic Sclerosis – Current Trends

  2017cites this paper
• Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis

  2017cites this paper
• Muscle involvement in systemic sclerosis: points to consider in clinical trials

  2017cites this paper
• Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)

  2017cites this paper
• Mercury as an environmental stimulus in the development of autoimmunity - A systematic review.

  2017cites this paper
• Musculoskeletal Involvement in Systemic Sclerosis: An Unexplored Aspect of the Disease

  2017cites this paper
• Perfil de autoanticuerpos y asociación con patrones inmuno-electroforéticos en pacientes con esclerosis sistémica

  2017cites this paper
• The Clinical Relevance of Antifibrillarin (anti‐U3‐RNP) Autoantibodies in Systemic Sclerosis

  2017cites this paper
• The Clinical Features of Myositis-Associated Autoantibodies: a Review

  2017cites this paper
• The clinical relevance of anti-fibrillarin (anti U3-RNP) autoantibodies in systemic sclerosis Short title: Anti-fibrillarin in systemic sclerosis

  2016influential citation
• Autoantibodies in Systemic Sclerosis

  2016cites this paper
• Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin.

  2016cites this paper
• Low doses of mercuric chloride cause the main features of anti-nucleolar autoimmunity in female outbred CFW mice

  2016cites this paper
• Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis

  2016cites this paper
• Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis

  2015cites this paper
• Scleroderma renal crisis.

  2015cites this paper
• Biomarker discovery in systemic sclerosis: state of the art

  2015cites this paper
• Autoprzeciwciała w twardzinie układowej* Autoantibodies in systemic sclerosis

  2015cites this paper
• [Autoantibodies in systemic sclerosis].

  2015cites this paper
• Caractéristiques cliniques associées aux anticorps anti-fibrillarine

  2015cites this paper
• Current management strategies for systemic sclerosis.

  2014cites this paper
• Musculoskeletal involvement in systemic sclerosis.

  2014cites this paper
• OP0285 The Pathogenic Role of Immune Complexes Containing Scleroderma-Specific Autoantibodies in the Inductor Phase of the Disease

  2014cites this paper
• Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis

  2014cites this paper
• Stressing on the nucleolus in cardiovascular disease.

  2014cites this paper
• Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients

  2013cites this paper
• Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors.

  2013cites this paper
• Autoantibodies in systemic sclerosis.

  2013cites this paper
• [Autoantibodies and their clinical characteristics in systemic sclerosis].

  2013cites this paper
• Ocena częstości występowania i znaczenia klinicznego przeciwciał przeciwfosfolipidowych u chorych na twardzinę układową

  2012cites this paper
• N-TproBNP as Biomarker in Systemic Sclerosis

  2012cites this paper
• The Clinical Aspects of Autoantibodies

  2012cites this paper
• South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome

  2012cites this paper
• Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis.

  2012influential citation
• Immune Complex Deposits as a Characteristic Feature of Mercury-Induced SLE-Like Autoimmune Process in Inbred and Outbred Mice

  2012cites this paper
• Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.

  2011cites this paper
• Skeletal and cardiac muscles involvement in systemic sclerosis.

  2011cites this paper
• Sensitivity of the Phadia EliA connective tissue disease screen for less common disease-specific autoantibodies

  2011cites this paper
• Systemic Sclerosis: Severe Involvement of Internal Organs

  2011cites this paper
• Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival Analysis

  2011cites this paper
• Systemic sclerosis – prognostic factors, disease activity and severity

  2011influential citation
• Envolvimento das musculaturas esquelética e cardíaca na esclerose sistêmica

  2011cites this paper
• A Patient with Diffuse Systemic Sclerosis with Hypertension and Acute Renal Failure

  2011cites this paper
• Nierenbeteiligung bei Kollagenosen

  2011cites this paper
• Caractérisation de l'interaction de l'auto-antigène ADN topoisomérase I avec les fibroblastes dans la sclérose systémique

  2011influential citation
• Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.

  2011cites this paper
• Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features

  2011influential citation
• Epidemiology of systemic sclerosis.

  2010cites this paper
• Localization and composition of renal immunodeposits in mice developing HgCl2-induced autoimmune process

  2010cites this paper
• Autoantibodies as predictive tools in systemic sclerosis

  2010cites this paper
• Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.

  2010cites this paper
• Autoantibody profiles in systemic sclerosis: Predictive value for clinical evaluation and prognosis

  2010cites this paper
• Secondary pulmonary hypertension

  2010cites this paper
• Isolated pulmonary veno-occlusive disease and pulmonary arterial thrombosis in systemic sclerosis – a lethal combination

  2010cites this paper
• Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis

  2009cites this paper
• [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].

  2009cites this paper
• Connective Tissue Disease Associated Pulmonary Arterial Hypertension: Special Cases?

  2009cites this paper
• clinique et approche diagnostique Autoantibodies in systemic sclerosis : clinical interest and diagnosis approach

  2009cites this paper
• Anti-U3 RNP autoantibodies in systemic sclerosis.

  2009cites this paper
• Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma.

  2008cites this paper
• Systemic sclerosis in an Afro-Caribbean population: a review of demographic and clinical features.

  2008cites this paper
• Diagnosis, management and prevention of scleroderma renal disease

  2008cites this paper
• Protein arginine methylation in health and disease.

  2008cites this paper
• Challenges and Controversies in Autoantibodies Associated with Systemic Rheumatic Diseases

  2007cites this paper
• Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes

  2007cites this paper